After liver transplantation for hepatitis-B-related diseases, patients currently receive lifelong treatment with hepatitis B immunoglobulin to prevent endogenous reinfection with hepatitis B virus (HBV). Active immunization with hepatitis B vaccine would be a preferable alternative; however, most at
T cells in transplantation immunity
✍ Scribed by N.A. Mitchison
- Publisher
- Elsevier Science
- Year
- 1989
- Tongue
- English
- Weight
- 373 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0165-2478
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We have previously shown that anti-Ly-6C monoclonal antibody (MAb) 2B6-F2 identifies a subset of (CBA % C57BL/6)FI splenic NK-I. I + natural T (NT) cells which kill the NK-sensitive YAC-I target in vitro. Furthermore, these Ly-6C+ cells are responsible for 4650% of in vitro YAC-I killing in all mous
Hepatitis B virus (HBV) recurrence after orthotopic liver transplantation (OLT) is associated with poor graft-and patientsurvival. Treatment with HBV-specific immunoglobulins (HBIG) in combination with nucleos(t)ide analogs is effective in preventing HBV reinfection of the graft and improving OLT ou
## Abstract Recent studies have revealed that Foxp3^+^CD25^+^CD4^+^ regulatory T cells (Tregs), which are physiologically engaged in the maintenance of immunological self‐tolerance, play critical roles for the control of antitumor immune responses. For example, a large number of Foxp3^+^Tregs infil
## Abstract A natural response acting to discriminate between allogeneic and syngeneic lymphocytes __in vivo__ is described for normal mice. Eighteen to 24 h after systemic injections of low doses of ^51^Cr‐labeled cells, less radioactivity is found in the lymph nodes after allogeneic transfer. The
## Abstract The resistance of animals to allogeneic tumor cells injected into the brain increases with age. The second‐set reaction in the brain of rats appears to be equally effective after preimmunization into the brain and preimmunization into the leg. Also, the presence of cytotoxic antibodies